These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35574447)

  • 21. Predicting Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Using Deep Learning of Diffusion Kurtosis MRI.
    Zhang XY; Wang L; Zhu HT; Li ZW; Ye M; Li XT; Shi YJ; Zhu HC; Sun YS
    Radiology; 2020 Jul; 296(1):56-64. PubMed ID: 32315264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment response prediction of neoadjuvant chemotherapy for rectal cancer by deep learning of colonoscopy images.
    Kato S; Miyoshi N; Fujino S; Minami S; Nagae A; Hayashi R; Sekido Y; Hata T; Hamabe A; Ogino T; Tei M; Kagawa Y; Takahashi H; Uemura M; Yamamoto H; Doki Y; Eguchi H
    Oncol Lett; 2023 Nov; 26(5):474. PubMed ID: 37809043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study.
    Feng L; Liu Z; Li C; Li Z; Lou X; Shao L; Wang Y; Huang Y; Chen H; Pang X; Liu S; He F; Zheng J; Meng X; Xie P; Yang G; Ding Y; Wei M; Yun J; Hung MC; Zhou W; Wahl DR; Lan P; Tian J; Wan X
    Lancet Digit Health; 2022 Jan; 4(1):e8-e17. PubMed ID: 34952679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rectal cancer response to neoadjuvant chemoradiotherapy evaluated with MRI: Development and validation of a classification algorithm.
    Rengo M; Landolfi F; Picchia S; Bellini D; Losquadro C; Badia S; Caruso D; Iannicelli E; Osti MF; Tombolini V; Carbone I; Giunta G; Laghi A
    Eur J Radiol; 2022 Feb; 147():110146. PubMed ID: 34998098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Genotype Signature for Predicting Pathologic Complete Response in Locally Advanced Rectal Cancer.
    Xiao WW; Li M; Guo ZW; Zhang R; Xi SY; Zhang XG; Li Y; Wu DQ; Ren YF; Pang XL; Wan XB; Li K; Zhou CL; Zhai XM; Liang ZK; Wang QX; Zeng ZF; Zhang HZ; Yang XX; Wu YS; Li M; Gao YH
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):482-491. PubMed ID: 33434612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer.
    Lou X; Zhou N; Feng L; Li Z; Fang Y; Fan X; Ling Y; Liu H; Zou X; Wang J; Huang J; Yun J; Yao J; Huang Y
    Front Oncol; 2022; 12():807264. PubMed ID: 35756653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
    Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Yi X; Pei Q; Zhang Y; Zhu H; Wang Z; Chen C; Li Q; Long X; Tan F; Zhou Z; Liu W; Li C; Zhou Y; Song X; Li Y; Liao W; Li X; Sun L; Pei H; Zee C; Chen BT
    Front Oncol; 2019; 9():552. PubMed ID: 31293979
    [No Abstract]   [Full Text] [Related]  

  • 29. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
    World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Application of convolutional neural network to risk evaluation of positive circumferential resection margin of rectal cancer by magnetic resonance imaging].
    Xu JH; Zhou XM; Ma JL; Liu SS; Zhang MS; Zheng XF; Zhang XY; Liu GW; Zhang XX; Lu Y; Wang DS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jun; 23(6):572-577. PubMed ID: 32521977
    [No Abstract]   [Full Text] [Related]  

  • 31. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
    Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
    [No Abstract]   [Full Text] [Related]  

  • 32. Deep learning-based artificial intelligence model to assist thyroid nodule diagnosis and management: a multicentre diagnostic study.
    Peng S; Liu Y; Lv W; Liu L; Zhou Q; Yang H; Ren J; Liu G; Wang X; Zhang X; Du Q; Nie F; Huang G; Guo Y; Li J; Liang J; Hu H; Xiao H; Liu Z; Lai F; Zheng Q; Wang H; Li Y; Alexander EK; Wang W; Xiao H
    Lancet Digit Health; 2021 Apr; 3(4):e250-e259. PubMed ID: 33766289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response prediction of neoadjuvant chemoradiation therapy in locally advanced rectal cancer using CT-based fractal dimension analysis.
    Tochigi T; Kamran SC; Parakh A; Noda Y; Ganeshan B; Blaszkowsky LS; Ryan DP; Allen JN; Berger DL; Wo JY; Hong TS; Kambadakone A
    Eur Radiol; 2022 Apr; 32(4):2426-2436. PubMed ID: 34643781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of deep learning on endoscopic images to assess the response of rectal cancer after chemoradiation.
    Haak HE; Gao X; Maas M; Waktola S; Benson S; Beets-Tan RGH; Beets GL; van Leerdam M; Melenhorst J
    Surg Endosc; 2022 May; 36(5):3592-3600. PubMed ID: 34642794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy: influencing factors and prognostic significance.
    Lu X; Qi R; Xu Y; Wang X; Cai Y; Wang C
    Int J Clin Exp Pathol; 2023; 16(6):124-132. PubMed ID: 37425225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI prediction of pathological response in locally advanced rectal cancer: when apparent diffusion coefficient radiomics meets conventional volumetry.
    Palmisano A; Di Chiara A; Esposito A; Rancoita PMV; Fiorino C; Passoni P; Albarello L; Rosati R; Del Maschio A; De Cobelli F
    Clin Radiol; 2020 Oct; 75(10):798.e1-798.e11. PubMed ID: 32712007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of pulp exposure risk of carious pulpitis based on deep learning.
    Wang L; Wu F; Xiao M; Chen YX; Wu L
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2023 Apr; 41(2):218-224. PubMed ID: 37056189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of an MRI-based radiomic nomogram to distinguish between good and poor responders in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
    Wang J; Liu X; Hu B; Gao Y; Chen J; Li J
    Abdom Radiol (NY); 2021 May; 46(5):1805-1815. PubMed ID: 33151359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Good response to neoadjuvant chemoradiotherapy predicts good oncological outcome in locally advanced rectal cancer.
    Zhang C; Xu L; Qin Q; Liu J; Tang X; Jiang N; Zhang Z; Li F; Cheng H; Chen J; Sun X
    Transl Cancer Res; 2019 Feb; 8(1):150-159. PubMed ID: 35116744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.